Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2, Randomized, Multicenter, Double-blind, Vehicle-controlled Study to Evaluate Safety and Efficacy of Three Doses of Estradiol Vaginal Capsule in Postmenopausal Women With Vulvovaginal Atrophy

NCT02670785 is registered in ClinicalTrials.gov with Warner Chilcott as lead sponsor.

NCT NCT02670785
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02670785 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2, Randomized, Multicenter, Double-blind, Vehicle-controlled Study to Evaluate Safety and Efficacy of Three Doses of Estradiol Vaginal Capsule in Postmenopausal Women With Vulvovaginal Atrophy
Lead sponsor
Warner Chilcott
Phase
Phase 2
Overall status
Completed
Start date
February 15, 2016
Completion date
November 14, 2016
Enrollment
203 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

dyspareunia, menopause, vulvovaginal atrophy